2022
DOI: 10.1016/j.addr.2022.114519
|View full text |Cite
|
Sign up to set email alerts
|

Scientific and regulatory activities initiated by the U.S. food and drug administration to foster approvals of generic dry powder inhalers: Quality perspective

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 10 publications
references
References 77 publications
0
0
0
Order By: Relevance